Table 1 Baseline characteristics of included studies regarding to WHO SSC compliance
Author | Year | Country | Study Design | Sampling technique | Sample Size | Proportion of SSC compliance | Quality of included studies(JBI) |
|---|---|---|---|---|---|---|---|
Tiruneh and Yetneberk [31] | 2020 | Ethiopia | Cross-sectional | Not stated | 3460 | 82.1% | 6 |
Mersh et al. [30] | 2021 | Ethiopia | Cross-sectional | Not stated | 100 | 100% | 6 |
Igaga et al. [21] | 2018 | Uganda | Prospective Cohort | Purposive | 859 | 41.7% | 7 |
Sibhatu et al. [25] | 2022 | Ethiopia | Retrospective CS | Stratified random sampling | 1603 | 67.6% | 8 |
Melekie and Getahun [23] | 2015 | Ethiopia | Prospective observational | Not stated | 282 | 39.7% | 8 |
Girma et al. [26] | 2022 | Ethiopia | Prospective CS | Convenient | 384 | 93.5% | 8 |
Bajracharya et al. [27] | 2021 | Nepal | Prospective CS | Convenient | 267 | 64% | 6 |
Ribeiro et al. [28] | 2019 | Brazil | Retrospective CS | Simple random | 423 | 95% | 6 |
Fridrich et al. [32] | 2022 | Swiss | Not stated | systematic | 8622 | 91% | 4 |
Ambulkar et al. [24] | 2018 | India | Prospective Observational | Convenient | 600 | 84.8% | 5 |
Allene [22] | 2020 | Ethiopia | Prospective Cohort | Convenient | 255 | 100% | 6 |
Cullati et al. [14] | 2014 | Swiss | Cross sectional | Not stated | 152 | 65% | 5 |
Tan et al. [33] | 2021 | China | Prospective CS | Not stated | 860 | 79.8% | 5 |
Mean score | 6.15 | ||||||